Inhibition of low density lipoprotein receptor expression by long-term exposure to phorbol ester via p38 mitogen-activated protein kinase pathway

被引:11
|
作者
Oh, J
Choi, YS
Kim, JW
Park, JY
Kim, SW
Park, KK
Pak, YK [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea
[2] Korea Natl Inst Hlth, Dept Genet Res, Seoul 122701, South Korea
[3] Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South Korea
[4] Pharmacogenechips Inc, Chunchon 200160, Kangwon Do, South Korea
关键词
atherosclerosis; cholesterol; gene expression; lipoproteins;
D O I
10.1002/jcb.20551
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proximal region -234 to (+58 bp) of low-density lipoprotein receptor (LDLR) is responsible for its up-regulation by sterol regulatory element binding protein (SREBP). However, the mechanism of sterol-independent repression of LDLR has not been determined yet. In this study, we observed that there was an early induction and a later repression of LDLR by phorbol ester WMA) in SK-Hep1 hepatocarcinoma cells and investigated the mechanisms through which PMA repressed LDLR transcription. SK-Hep1 cells were exposed to PMA and LDLR mRNA was evaluated by RTPCR and Northern blot analysis. The effect of phorbol ester on LDLR transcriptional activity was studied using transient transfection of LDLR promoter-luciferase constructs. Overexpression of N-SREBP-2, a dominant positive SREBP2, did not reverse the PMA-repressed LDLR promoter activity. Serial deletion of LDLR promoter revealed that the region between -1,563 and -1,326 was responsible for the repression. The pretreatment with SB202190, an inhibitor for p38 mitogen-activated protein kinase pathway (p38-MAPK), but not other signaling inhibitors, reversed the PMA-induced repression. The 24 h-treatment with PMA efficiently arrested the SK-Hep1 cell cycle at G(0)/G(1) as demonstrated by FACS analysis and decreased the 3 H-thymidine incorporation. The PMA-induced repression of LDLR transcription may be exerted by the factor(s), not SREBP2, induced or modified by p38-MAPK-mediated signaling pathway and associated with cell cycle blockage.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 50 条
  • [1] Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression
    Mehta, KD
    Miller, L
    TRENDS IN CARDIOVASCULAR MEDICINE, 1999, 9 (07) : 201 - 205
  • [2] Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway
    Hess, A
    Wijayanti, N
    Neuschäfer-Rube, AP
    Katz, N
    Kietzmann, T
    Immenschuh, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) : 45419 - 45434
  • [3] Inhibition of p38 Mitogen-Activated Protein Kinase Pathway as Prophylaxis of Postoperative Ileus in Mice
    Wehner, Sven
    Straesser, Stefan
    Vilz, Tim O.
    Pantelis, Dimitrios
    Sielecki, Thais
    De la Cruz, Vidal F.
    Hirner, Andreas
    Kalff, Joerg C.
    GASTROENTEROLOGY, 2009, 136 (02) : 619 - 629
  • [4] Dehydroeplandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase
    Ashida, K
    Goto, K
    Zhao, Y
    Okabe, T
    Yanase, T
    Takayanagi, R
    Nomura, M
    Nawata, H
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2005, 1728 (1-2): : 84 - 94
  • [5] p38 mitogen-activated protein kinase and pain
    Mai, Lijia
    Zhu, Xiao
    Huang, Fang
    He, Hongwen
    Fan, Wenguo
    LIFE SCIENCES, 2020, 256
  • [6] Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition
    Takaya Handa
    Keita P. Mori
    Akira Ishii
    Shoko Ohno
    Yugo Kanai
    Haruko Watanabe-Takano
    Akihiro Yasoda
    Takashige Kuwabara
    Nobuyuki Takahashi
    Naoki Mochizuki
    Masashi Mukoyama
    Motoko Yanagita
    Hideki Yokoi
    Scientific Reports, 11
  • [7] Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition
    Handa, Takaya
    Mori, Keita P.
    Ishii, Akira
    Ohno, Shoko
    Kanai, Yugo
    Watanabe-Takano, Haruko
    Yasoda, Akihiro
    Kuwabara, Takashige
    Takahashi, Nobuyuki
    Mochizuki, Naoki
    Mukoyama, Masashi
    Yanagita, Motoko
    Yokoi, Hideki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Mitogen-Activated Protein Kinase p38 Pathway in Venous Ulcer Fibroblasts
    Raffetto, Joseph D.
    Gram, Christopher H.
    Overman, Kristen C.
    Menzoian, James O.
    VASCULAR AND ENDOVASCULAR SURGERY, 2008, 42 (04) : 367 - 374
  • [9] The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
    Schett, G.
    Zwerina, J.
    Firestein, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) : 909 - 916
  • [10] Inhibition of p38 Mitogen-Activated Protein Kinase Enhances the Apoptosis Induced by Oxidized Low-Density Lipoprotein in Endothelial Progenitor Cells
    Tie, Guodong
    Yan, Jinglian
    Messina, Julia A.
    Raffai, Robert L.
    Messina, Louis M.
    JOURNAL OF VASCULAR RESEARCH, 2015, 52 (06) : 361 - 371